XJPX7730
Market cap926mUSD
Jan 17, Last price
1,469.50JPY
1D
1.70%
1Q
-15.57%
Jan 2017
58.18%
Name
Mani Inc
Chart & Performance
Profile
Mani, Inc. engages in the research, development, manufacture, and distribution of medical devices and dental instruments in Japan and internationally. The company offers surgical instruments, such as maniplers, vessel knives, knives, stainless wire needles, and saws used in surgical operations for incision, cutting, and suture; and ophthalmic instruments, including ophthalmic sutures and knives, and trocar kits for eye surgeries, including cataract operations. It also provides surgical eyeless and eyed needles; and dental instruments, such as endodontic instruments, endodontic rotary instruments, root canal obturation, diamond and carbide burs, finishing and polishing instruments, sutures and surgical needles, endodontic micro-accessories, and endodontic accessories. In addition, the company imports and sells medical devices. Mani, Inc. was founded in 1956 and is headquartered in Utsunomiya, Japan.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2024‑08 | 2023‑08 | 2022‑08 | 2021‑08 | 2020‑08 | 2019‑08 | 2018‑08 | 2017‑08 | 2016‑08 | 2015‑08 | |
Income | ||||||||||
Revenues | 28,513,000 16.44% | 24,488,000 19.95% | 20,416,000 18.77% | |||||||
Cost of revenue | 10,616,000 | 11,253,000 | 9,401,000 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 17,897,000 | 13,235,000 | 11,015,000 | |||||||
NOPBT Margin | 62.77% | 54.05% | 53.95% | |||||||
Operating Taxes | 2,137,000 | 2,064,000 | 2,129,000 | |||||||
Tax Rate | 11.94% | 15.60% | 19.33% | |||||||
NOPAT | 15,760,000 | 11,171,000 | 8,886,000 | |||||||
Net income | 6,286,000 5.59% | 5,953,000 12.53% | 5,290,000 23.28% | |||||||
Dividends | (3,646,000) | (3,149,000) | (2,362,000) | |||||||
Dividend yield | 1.88% | 1.69% | 1.37% | |||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
Debt | ||||||||||
Debt current | 41,000 | 87,000 | ||||||||
Long-term debt | 127,000 | 75,000 | 147,000 | |||||||
Deferred revenue | (129,000) | (68,000) | ||||||||
Other long-term liabilities | 889,000 | 916,000 | 886,000 | |||||||
Net debt | (22,052,000) | (25,837,000) | (23,012,000) | |||||||
Cash flow | ||||||||||
Cash from operating activities | 7,820,000 | 8,026,000 | 6,559,000 | |||||||
CAPEX | (7,681,000) | (3,720,000) | (1,944,000) | |||||||
Cash from investing activities | (6,652,000) | (4,016,000) | (2,173,000) | |||||||
Cash from financing activities | (3,703,000) | (3,251,000) | (2,444,000) | |||||||
FCF | 6,956,000 | 11,505,000 | 6,804,000 | |||||||
Balance | ||||||||||
Cash | 21,662,000 | 25,427,000 | 22,729,000 | |||||||
Long term investments | 517,000 | 526,000 | 517,000 | |||||||
Excess cash | 20,753,350 | 24,728,600 | 22,225,200 | |||||||
Stockholders' equity | 49,211,000 | 51,837,000 | 47,502,000 | |||||||
Invested Capital | 32,511,650 | 23,142,400 | 22,974,800 | |||||||
ROIC | 56.64% | 48.45% | 40.41% | |||||||
ROCE | 33.60% | 27.57% | 24.33% | |||||||
EV | ||||||||||
Common stock shares outstanding | 98,496 | 98,471 | 98,426 | |||||||
Price | 1,966.50 3.64% | 1,897.50 8.06% | 1,756.00 -19.34% | |||||||
Market cap | 193,691,930 3.66% | 186,848,722 8.11% | 172,836,056 -19.34% | |||||||
EV | 171,639,930 | 161,011,722 | 149,824,056 | |||||||
EBITDA | 20,167,000 | 15,152,000 | 12,760,000 | |||||||
EV/EBITDA | 8.51 | 10.63 | 11.74 | |||||||
Interest | 6,000 | 2,000 | 2,000 | |||||||
Interest/NOPBT | 0.03% | 0.02% | 0.02% |